These compounds may interact with:
Cannabinoid receptor 1
Potentially involved in: obesity; attention deficit hyperactivity disorder; carcinoma; cannabis dependence; pain agnosia; schizophrenia; substance abuse; alcohol dependence; epilepsy; withdrawal disorder; multiple sclerosis; amnestic disorder; post-traumatic stress disorder; huntington's disease; parkinson's disease; cancer; toxic encephalopathy; diabetes mellitus; nicotine dependence; transient tic disorder
Disease data sourced from Pharos.